ALN-ANG

N/A

Report date: 2021/12/02 15:08:18
NME

Base Information

Drug NameALN-ANG
Drug Alias NameALN-ANG
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiopoietin like 3 inhibitorsRNA interference
TargetsAngiopoietin like 3
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlnylam Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHyperlipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A